for Physicians
for Patients

Research Project

Project Title:

A multicenter, randomized, double-blind, parallel group, placebo-controlled study to assess safety, tolerability, pharmacokinetics and pharmacodynamics of BI 764198 administered orally once daily for 12 weeks in patients with focal segmental glomeruloscle

Project Type:

 Clinical Trial, Enrolment ongoing

Disease group(s):

 Immune glomerulopathies

Project Summary:

 A multicenter, randomized, double-blind, parallel group, placebo-controlled study to assess safety, tolerability, pharmacokinetics and pharmacodynamics of BI 764198 administered orally once daily for 12 weeks in patients with focal segmental glomerulosclerosis.

Lead principal investigator(s):

 Bologna La Manna, Bologna

Co-investigator(s):

 Olga Baraldi, Bologna
Francesco Tondolo, Bologna
Elisa Gessaroli, Bologna

Project Period:

 09/2022   -   12/2026

Sponsors:

 Industry
« Back to research page